| Literature DB >> 20409380 |
Sari Rantala1, Susanna Vahakuopus, Jaana Vuopio-Varkila, Risto Vuento, Jaana Syrjanen.
Abstract
We conducted a retrospective population-based study of 140 episodes of Streptococcus dysgalactiae subsp. equisimilis bacteremia occurring in Finland during 1995-2004. Rare emm types were associated with more severe disease and increased mortality rates. Skin and soft tissue infections were more frequent clinical signs among cases caused by common emm types.Entities:
Mesh:
Substances:
Year: 2010 PMID: 20409380 PMCID: PMC2953979 DOI: 10.3201/eid1605.080803
Source DB: PubMed Journal: Emerg Infect Dis ISSN: 1080-6040 Impact factor: 6.883
Figure 1emm types of 138 Streptococcus dysgalactiae subsp. equisimilis bacteremic isolates obtained during 1995–2004, Finland. NT, nontypeable.
Disease severity among 138 episodes of Streptococcal dysgalactiae subsp. equisimilis bacteremia, Finland, 1995–2004*
| Disease severity | No. (%) common | No. (%) rare | Odds ratio (95% CI) | p value† |
|---|---|---|---|---|
| 30-day mortality rate | 11 (11) | 12 (29) | 3.2 (1.3–8.1) | 0.01 |
| Patient admitted to ICU | 5 (5) | 6 (15) | 3.2 (0.9–11) | 0.084 |
| Patient death or ICU treatment | 12 (12) | 15 (37) | 4.1 (1.7–9.8) | 0.001 |
| Hypotension‡ | 13 (13) | 10 (24) | 2.1 (0.8–5.2) | 0.113 |
| DIC§ | 2 (2) | 6 (15) | 8.1 (1.6–42.3) | 0.009 |
| Multiorgan failure | 2 (2) | 4 (10) | 5.1 ( 0.9–29.2) | 0.064 |
| STSS¶ | 2 (2) | 4 (10) | 5.1 ( 0.9–29.2) | 0.064 |
*CI, confidence interval; ICU, intensive care unit; DIC, disseminated intravascular coagulation; STSS, streptococcal toxic shock syndrome. Patients who had both clinical data and isolates available. †χ² test or Fisher exact test as appropriate. ‡Hypotensive (BP <90 mm Hg) at least once 0–2 days after positive blood culture. §Thrombocyte count <100 x 109/L. ¶The definition of STSS was based on a consensus definition, including identification of β-hemolytic streptococci from a normally sterile site, septic shock, and multiorgan failure.
Characteristics of recurrent episodes of group G Streptococcal dysgalactiae subsp. equisimilis bacteremia, Finland, 1995–2004*
| Patient no. | Time to recurrence, mo | Clinical signs | PFGE pattern | |||
|---|---|---|---|---|---|---|
| Episode 1 | Episode 2 | Episode 3 | ||||
| 1 | stG6 | stG6 | stG6 | 15; 3 | Cellulitis | Unique, identical in episodes 1–3 |
| 2 | stG6 | stG6 | 68 | Cellulitis | Unique, identical in episodes 1 and 2 | |
| 3 | stG480† | stG480 | 28 | Spondylitis | Unique, identical in episodes 1 and 2 | |
| 4 | stG480 | NA‡ | 21 | Cellulitis | Unique | |
*PFGE, pulsed-field gel electrophoresis. †Blood culture taken outside Pirkanmaa Health District, isolate available. ‡Blood culture taken outside Pirkanmaa Health District, no isolate available.
Figure 2Dendrogram and pulsed-field gel electrophoresis (PFGE) profiles of the strains isolated from patients with recurrent group G Streptococcus dysgalagtiae subsp. equisimilis bacteremia, Finland. Dendogram was generated by using Bionumerics software (Applied Maths, Kortrijk, Belgium) with a 1.0% lane optimization and 1.5% band position tolerance.